CRYSTALLINE DICHLORHYDRATE SALT FORM ((1S) -1 - (((2S) -2- (5- (4 '- (2 - ((2S) -1 - ((2S) -2 - ((METOXYCARBONYL - 3-MET (ILBUTANOYL) -2-PYROLIDINYL) -1H-IMIDAZOL-5-IL) -4-BIPHYLYL) -1H-IMIDAZOLE-2-IL) -1-PYROLIDINYL) CARBONYL) -2-METELPROPY L) METHYL CARBAMATE

摘要

The present disclosure generally relates to a crystalline form of methyl ((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1 H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt. The present disclosure also generally relates to a pharmaceutical composition comprising a crystalline form, as well as methods of using a crystalline form in the treatment of Hepatitis C and methods for obtaining such crystalline form.